BUPE2021.COMBUPE2021.COM
  • Home
  • Presentations
  • Posters
  • Info
    • ——————————
      • Call For Presentations, Posters, etc
      • CME Information
        • Conference Chairs
      • Presentations – Preview
    • ——————————
      • Press & Media
        • Contact Us
        • Speakers
    • ——————————
      • Conference Information
      • Terms and conditions
      • Tickets
    • ——————————
      • Educational Support
      • Satellite Symposia
      • Sponsorship & Exhibits
  • Register Now to Watch
  • Login
  • Get Started Now!
  • Home
  • Presentations
  • Posters
  • Info
    • ——————————
      • Call For Presentations, Posters, etc
      • CME Information
        • Conference Chairs
      • Presentations – Preview
    • ——————————
      • Press & Media
        • Contact Us
        • Speakers
    • ——————————
      • Conference Information
      • Terms and conditions
      • Tickets
    • ——————————
      • Educational Support
      • Satellite Symposia
      • Sponsorship & Exhibits
  • Register Now to Watch
  • Login
  • Get Started Now!
Cmes

Cmes

Course Directors: Mellar P. Davis, MD, FCCP, FAAHPM, Mary Lynn McPherson, PharmD, MA, MDE, BCPS, CPE

Learning Objectives

At the end of this educational activity, participants should be able to:

  • Describe the therapeutic benefits of buprenorphine and highlight indications for its use in acute, chronic and cancer pain.
  • Explain interactions of buprenorphine with other opioids.
  • Explain the appropriate application of buprenorphine in pain patients and those with co-morbid substance use disorder.
  • Explain the concepts and practice of micro-dosing, rotation and titration.
  • Recognize the legal and regulatory implications of prescribing opioids that arise when treating individuals in pain.
  • Explain the basic pharmacology of buprenorphine and utilize and promote evidence-based approaches for clinical treatment.
  • Describe the various delivery methods for buprenorphine in the management of pain.

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Weston Medical Publishing. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Boston University School of Medicine designates this enduring activity for a maximum of 9.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy

Boston University School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. 

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.

Faculty/Planners

Jacqueline Cleary is a speaker for Genomind, a consultant and on the AcelRx Pharmaceuticals Advisory Board and a consultant for Remitigate.  She does plan on discussing unlabeled/investigational uses of a commercial product.

Jeffrey Bettinger is on the Hisamitsu America, Inc. and PainScript LLC. Advisory Boards.

Kathleen Broglio does plan on discussing unlabeled/investigational uses of a commercial product.

Lynn Webster is a principal investigator for Cognifiscence and a consultant for BDSI, Clarity Science, Ensys.., KempPharm, Salix and Shionogi.

Gurpreet Singh Guilani does plan on discussing unlabeled/investigational uses of a commercial product.

Jordana Laks, MD, CME Reviewer, has no relevant financial relationships.

All other faculty/planners have no relevant financial relationships and do not plan on discussing unlabeled/investigational uses of a commercial product.


Claim your credit:

Please click here to register for BUPE2021.com to access presentations and CME details.
Or login in to access presentations and CME details.

Disclaimer

THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.  NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.

Off Label Statement: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The faculty have been asked to disclose this information when presented. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Cancellations: As the content is available on this website through the end of June, 2022, there are no refunds for cancellations however we will address hardships on a case by case basis.  Substitutions of enrolled registrants must be made in writing. If for any reason this conference is cancelled, the conference organizers and sponsors do not accept responsibility for covering airfare, hotel or other costs incurred by conference registrants. The speakers and agenda of this program are subject to change without notice due to unforeseen circumstances beyond the control of conference presenters.

ADA Support: Weston Medical Publishing, LLC fully comply with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact our offices at 781-899-2702 Ext. 108 in order to receive services.

The Journal of Opioid Management presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

The speakers and agenda of this program are subject to change without notice due to unforeseen circumstances beyond the control of conference presenters.

BUPE2021 is presented by the Journal of Opioid Management. We are dedicated to presenting the latest research and practice for managing patients on opioid therapies.

INFORMATION
  • Terms and conditions
  • Privacy Statement
Looking for more? Sign up today!

    Contact Us
    jom@pnpco.com
    Copyright 2022 Weston Medical Publishing, LLC - All Rights Reserved
    This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
    Privacy & Cookies Policy

    Privacy Overview

    Privacy Statement


    Privacy and User Data Policy

    GDPR Update:

    The data collected from registered and non-registered users of this journal falls within the scope of the standard functioning of peer-reviewed journals. It includes information that makes communication possible for the editorial process; it is used to informs readers about the authorship and editing of content; it enables collecting aggregated data on readership behaviors, as well as tracking geopolitical and social elements of scholarly communication.

    This journal’s editorial team uses this data to guide its work in publishing and improving this journal. Data that will assist in developing this publishing platform may be shared with its developer Public Knowledge Project in an anonymized and aggregated form, with appropriate exceptions such as article metrics. The data will not be sold by this journal or PKP nor will it be used for purposes other than those stated here. The authors published in this journal are responsible for the human subject data that figures in the research reported here.

    Those involved in editing this journal seek to be compliant with industry standards for data privacy, including the European Union’s General Data Protection Regulation (GDPR) provision for “data subject rights” that include (a) breach notification; (b) right of access; (c) the right to be forgotten; (d) data portability; and (e) privacy by design. The GDPR also allows for the recognition of “the public interest in the availability of the data,” which has a particular saliency for those involved in maintaining, with the greatest integrity possible, the public record of scholarly publishing.

    Requests per item (a) through (e) above should be sent to the journal's mailbox, jom(at)pnpco.com

    The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

    What Data does this Website Process?

    The system, based the PKP Open Journal System applications, process personal data as a fundamental part of their operations. Most data is only provided by consent, ie. through manual user registration, though some visitation data (eg. cookies, usage logs) may also be recorded.

    User Registration Data

    When a visitor creates a user account in a PKP application, the following personal information is processed and stored (with some minor variation between OMP and OJS, and from version to version):

    ●   Salutation

    ●   First name*

    ●   Middle name

    ●   Last name*

    ●   Suffix

    ●   Username

    ●   Gender

    ●   Password (encrypted)

    ●   Email address*

    ●   ORCiD ID

    ●   Website

    ●   Mailing Address

    ●   Country

    ●   Phone

    ●   Fax

    ●   Affiliation

    ●   Biography

    ●   Registration date

    ●   Last login date

    ●   Locales

    ●   Reviewing interests

    ●   Role registrations (author, reader, and/or reviewer)

    Only the username, first name, last name, email and password fields are required.

    Storage

    This information is stored in the application database. Only the user password

    is encrypted.

    Availability and Access

    This information is available to the user via their User Profile (and, with the exception of the username and dates, can be edited). System administrators, journal managers, and editors can also access and edit this data (except the username and dates) via the application back end. The data can be downloaded by journal managers in XML format. The data is not otherwise publicly available.

    Erasure

    This data can be erased by the journal manager using the Merge Users tool, without affecting any editorial records. The erasure is subject to the considerations raised in the section “Scholarly Publishing, Data Privacy, and the Public Interest”, above.

    Contributor Metadata Information

    When a manuscript is submitted to a PKP application, contributor information is included. Contributors can be authors, translators, volume editors, and so on. This information is stored as submission metadata and is provided as part of any published manuscript record. The following contributor information is collected:

    ●   Salutation

    ●   First name*

    ●   Middle name

    ●   Last name*

    ●   Email address*

    ●   Suffix

    ●   ORCiD ID

    ●   Website

    ●   Country*

    ●   Affiliation

    ●   Biography

    Only the first name, last name, email address and country fields are required.

    Storage

    This information is stored in the application database.

    Data Transfer

    We do not sell or transfer to third parties user information from this system.

    General Visitor Information

    PKP applications also collect general visitor usage data, including:

    ● Cookie information, to manage session history. Cookies are required to maintain a login session in PKP applications.

    ● Optionally, detailed usage log data, including: IP address; pages visited; date visited; and browser information, in application log files, as part of the Usage Statistics plugin. An anonymization option is available to privatize this information.

    ● Optionally, country, region and city information, in the metrics database. This data collection requires additional setup and is not enabled by default.

    Other data may be tracked, either on the server or via third parties:

    ● Script loads from CDN servers;

    ● IP address information (including date, browser, etc.) in web server logs (separate from application log files as part of the Usage Statistics plugin).

    Detailed instructions in limiting the amount of data you collect, and providing consent for the data you collect, can be found below.

    Storage

    ● Cookies: A cookie (usually titled “OJSSID” or “OMPSID”) is created when first visiting a PKP application and is stored on the visitor’s computer. It is only used to store a session ID, and to facilitate logins. (If the visitor blocks cookies, OJS will still work properly, though they will not be able to log in.)

    ● Usage Statistics log files: As part of the usage statistics framework and plugin, OJS may store detailed application log files in the submission files directory (configured as the files_dir parameter in the OJS config.inc.php file), in a “usageStats” directory.

    ● Geographical data: Filtered usage data, including possibly geographic data, is also stored in the OJS database, in a “metrics” table.

    Availability and Access

    ● Cookies: These are available via the visitor’s browser settings.

    ● Usage Statistics log files: Only individuals with server file access can access application log files.

    ● Geographical data: Journal Managers can access filtered usage data by using the OJS usage report plugins.

    Erasure

    ● Cookies: These can be deleted via the visitor browser.

    ● Usage Statistics log files: These can be erased by system administrators with file access.

    ● Geographical data: This can only be erased by deleting records from the database directly, which also typically requires system administrator access.

    Portions of this privacy statement are copyright by Simon Fraiser University Licensed wth CC4.0-BY.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
    Non-necessary
    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
    SAVE & ACCEPT